NVEC 10-Q Quarterly Report Dec. 31, 2010

NVE CORP /NEW/

10-Ks and 10-Qs

10-Q	Quarter ended Sept. 30, 2025
10-Q	Quarter ended June 30, 2025
10-K	Fiscal year ended March 31, 2025
10-Q	Quarter ended Dec. 31, 2024
10-Q	Quarter ended Sept. 30, 2024
10-Q	Quarter ended June 30, 2024
10-K	Fiscal year ended March 31, 2024
10-Q	Quarter ended Dec. 31, 2023
10-Q	Quarter ended Sept. 30, 2023
10-Q	Quarter ended June 30, 2023
10-K	Fiscal year ended March 31, 2023
10-Q	Quarter ended Dec. 31, 2022
10-Q	Quarter ended Sept. 30, 2022
10-Q	Quarter ended June 30, 2022
10-K	Fiscal year ended March 31, 2022
10-Q	Quarter ended Dec. 31, 2021
10-Q	Quarter ended Sept. 30, 2021
10-Q	Quarter ended June 30, 2021
10-K	Fiscal year ended March 31, 2021
10-Q	Quarter ended Dec. 31, 2020
10-Q	Quarter ended Sept. 30, 2020
10-Q	Quarter ended June 30, 2020
10-K	Fiscal year ended March 31, 2020
10-Q	Quarter ended Dec. 31, 2019
10-Q	Quarter ended Sept. 30, 2019
10-Q	Quarter ended June 30, 2019
10-K	Fiscal year ended March 31, 2019
10-Q	Quarter ended Dec. 31, 2018
10-Q	Quarter ended Sept. 30, 2018
10-Q	Quarter ended June 30, 2018
10-K	Fiscal year ended March 31, 2018
10-Q	Quarter ended Dec. 31, 2017
10-Q	Quarter ended Sept. 30, 2017
10-Q	Quarter ended June 30, 2017
10-K	Fiscal year ended March 31, 2017
10-Q	Quarter ended Dec. 31, 2016
10-Q	Quarter ended Sept. 30, 2016
10-Q	Quarter ended June 30, 2016
10-K	Fiscal year ended March 31, 2016
10-Q	Quarter ended Dec. 31, 2015
10-Q	Quarter ended Sept. 30, 2015
10-Q	Quarter ended June 30, 2015
10-K	Fiscal year ended March 31, 2015
10-Q	Quarter ended Dec. 31, 2014
10-Q	Quarter ended Sept. 30, 2014
10-Q	Quarter ended June 30, 2014
10-K	Fiscal year ended March 31, 2014
10-Q	Quarter ended Dec. 31, 2013
10-Q	Quarter ended Sept. 30, 2013
10-Q	Quarter ended June 30, 2013
10-K	Fiscal year ended March 31, 2013
10-Q	Quarter ended Dec. 31, 2012
10-Q	Quarter ended Sept. 30, 2012
10-Q	Quarter ended June 30, 2012
10-K	Fiscal year ended March 31, 2012
10-Q	Quarter ended Dec. 31, 2011
10-Q	Quarter ended Sept. 30, 2011
10-Q	Quarter ended June 30, 2011
10-K	Fiscal year ended March 31, 2011
10-Q	Quarter ended Dec. 31, 2010
10-Q	Quarter ended Sept. 30, 2010
10-Q	Quarter ended June 30, 2010
10-K	Fiscal year ended March 31, 2010
10-Q	Quarter ended Dec. 31, 2009

PROXIES

DEF 14A	Filed on June 23, 2025
DEF 14A	Filed on Aug. 1, 2024
DEF 14A	Filed on June 17, 2024
DEF 14A	Filed on Aug. 3, 2023
DEF 14A	Filed on June 20, 2023
DEF 14A	Filed on Aug. 4, 2022
DEF 14A	Filed on June 21, 2022
DEF 14A	Filed on June 21, 2021
DEF 14A	Filed on June 22, 2020
DEF 14A	Filed on June 17, 2019
DEF 14A	Filed on June 18, 2018
DEF 14A	Filed on June 19, 2017
DEF 14A	Filed on June 20, 2016
DEF 14A	Filed on June 22, 2015
DEF 14A	Filed on June 23, 2014
DEF 14A	Filed on June 24, 2013
DEF 14A	Filed on June 25, 2012
DEF 14A	Filed on June 30, 2011
DEF 14A	Filed on June 21, 2010
DEF 14A	Filed on None

10-Q 1 q3q11.htm QUARTERLY REPORT FOR THE PERIOD ENDED DEC. 31, 2010

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

(Mark One)
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended December 31, 2010

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to

Commission File Number: 000-12196

NVE CORPORATION
(Exact name of registrant as specified in its charter)

Minnesota		41-1424202
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

11409 Valley View Road, Eden Prairie, Minnesota		55344
(Address of principal executive offices)		(Zip Code)

(952) 829-9217
(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

[X] Yes [ ] No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

[ ] Yes [ ] No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer [ ]	Accelerated filer [X]
Non-accelerated filer [ ] (Do not check if a smaller reporting company)	Smaller reporting company [ ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). [ ] Yes [X] No

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
Common Stock, $0.01 Par Value – 4,766,198 shares outstanding as of January 14, 2011

NVE CORPORATION
QUARTERLY REPORT ON FORM 10-Q
TABLE OF CONTENTS

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

Balance Sheets

Statements of Income for the Quarters Ended December 31, 2010 and 2009

Statements of Income for the Nine Months Ended December 31, 2010 and 2009

Statements of Cash Flows

Notes to Financial Statements

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Item 4. Controls and Procedures

PART II. OTHER INFORMATION

Item 1A. Risk Factors

Item 6. Exhibits

SIGNATURES

Table of Contents

PART I–FINANCIAL INFORMATION

Item 1. Financial Statements.

NVE CORPORATION
BALANCE SHEETS

	(Unaudited) Dec. 31, 2010		March 31, 2010*
ASSETS
Current assets
Cash and cash equivalents	$	1,178,409	$	1,389,288
Marketable securities, short term		4,455,249		1,566,666
Accounts receivable, net of allowance for uncollectible accounts of $15,000		3,471,435		4,221,564
Inventories		3,164,158		1,706,427
Prepaid expenses and other assets	1,102,838		781,294
Total current assets		13,372,089		9,665,239
Fixed assets
Machinery and equipment		5,954,570		5,617,136
Leasehold improvements	612,682		450,546
		6,567,252		6,067,682
Less accumulated depreciation	5,146,230		4,857,819
Net fixed assets		1,421,022		1,209,863
Marketable securities, long term	52,677,162		46,587,812
Total assets	$	67,470,273	$	57,462,914

LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities
Accounts payable	$	482,412	$	665,782
Accrued payroll and other		833,615		720,867
Deferred taxes	130,445		102,138
Deferred revenue	-		20,833
Total current liabilities		1,446,472		1,509,620

Shareholders’ equity
Common stock		47,662		47,006
Additional paid-in capital		20,565,148		20,169,924
Accumulated other comprehensive income		1,113,327		1,129,726
Retained earnings	44,297,664		34,606,638
Total shareholders’ equity	66,023,801		55,953,294
Total liabilities and shareholders’ equity	$	67,470,273	$	57,462,914

*The March 31, 2010 Balance Sheet is derived from the audited financial statements contained in our Annual Report on Form 10-K for the fiscal year ended March 31, 2010.

See accompanying notes.

3

Table of Contents

NVE CORPORATION
STATEMENTS OF INCOME
(Unaudited)

	Quarter Ended Dec. 31
	2010		2009
Revenue
Product sales	$	6,686,451	$	5,292,228
Contract research and development	1,277,057		1,332,629
Total revenue		7,963,508		6,624,857
Cost of sales	2,461,798		2,102,855
Gross profit		5,501,710		4,522,002
Expenses
Selling, general, and administrative		638,223		548,973
Research and development	330,681		251,625
Total expenses	968,904			800,598
Income from operations		4,532,806	3,721,404
Interest income	512,203		414,669
Income before taxes		5,045,009	4,136,073
Provision for income taxes	1,661,090			1,368,590
Net income	$	3,383,919	$	2,767,483
Net income per share – basic	$	0.71	$	0.59
Net income per share – diluted	$	0.70	$	0.57
Weighted average shares outstanding
Basic		4,743,643		4,700,583
Diluted		4,866,617		4,855,948

See accompanying notes.

4

Table of Contents

NVE CORPORATION
STATEMENTS OF INCOME
(Unaudited)

	Nine Months Ended Dec. 31
	2010		2009
Revenue
Product sales	$	19,290,839	$	16,003,710
Contract research and development	3,723,123			3,964,180
Total revenue		23,013,962		19,967,890
Cost of sales	7,142,528			5,979,378
Gross profit		15,871,434		13,988,512
Expenses
Selling, general, and administrative		1,901,156		1,807,050
Research and development	982,217			810,486
Total expenses	2,883,373			2,617,536
Income from operations		12,988,061		11,370,976
Interest income	1,485,664		1,177,892
Income before taxes		14,473,725		12,548,868
Provision for income taxes	4,782,699			4,148,270
Net income	$	9,691,026	$	8,400,598
Net income per share – basic	$	2.06	$	1.79
Net income per share – diluted	$	2.00	$	1.73
Weighted average shares outstanding
Basic		4,714,989		4,689,849
Diluted		4,837,963		4,845,150

See accompanying notes.

5

Table of Contents

NVE CORPORATION
STATEMENTS OF CASH FLOWS
(Unaudited)

	Nine Months Ended Dec. 31
	2010			2009
OPERATING ACTIVITIES
Net income	$	9,691,026		$	8,400,598
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation		290,798			274,137
Stock-based compensation		76,720			100,842
Excess tax benefits		(160,015	)		(280,448	)
Deferred income taxes		174,391			271,281
Changes in operating assets and liabilities:
Accounts receivable		750,129			438,350
Inventories		(1,457,731	)		455,404
Prepaid expenses and other assets		(321,544	)		(318,885	)
Accounts payable and accrued expenses		(70,622	)		112,742
Deferred revenue		(20,833	)		(62,500	)
Net cash provided by operating activities		8,952,319			9,391,521

INVESTING ACTIVITIES
Purchases of fixed assets		(501,957	)		(257,952	)
Purchases of marketable securities		(10,553,771	)		(10,922,540	)
Proceeds from maturities and sales of marketable securities		1,573,370			175,256
Net cash used in investing activities		(9,482,358	)		(11,005,236	)

FINANCING ACTIVITIES
Net proceeds from sale of common stock		159,145			622,423
Excess tax benefits		160,015			280,448
Net cash provided by financing activities		319,160			902,871

Decrease in cash and cash equivalents		(210,879	)		(710,844	)
Cash and cash equivalents at beginning of period	1,389,288				1,875,063

Cash and cash equivalents at end of period	$	1,178,409		$	1,164,219

Supplemental disclosures of cash flow information:
Cash paid during the period for income taxes	$	4,794,742		$	4,067,438

See accompanying notes.

6

Table of Contents

NVE CORPORATION
NOTES TO FINANCIAL STATEMENTS
(Unaudited)

NOTE 1. DESCRIPTION OF BUSINESS
We develop and sell devices that use spintronics, a nanotechnology that relies on electron spin rather than electron charge to acquire, store, and transmit information.

NOTE 2. INTERIM FINANCIAL INFORMATION
The accompanying unaudited financial statements of NVE Corporation are prepared consistent with accounting principles generally accepted in the United States and in accordance with Securities and Exchange Commission rules and regulations. In the opinion of management, these financial statements reflect all adjustments, consisting only of normal and recurring adjustments, necessary for a fair presentation of the financial statements. Although we believe that the disclosures are adequate to make the information presented not misleading, it is suggested that these unaudited financial statements be read in conjunction with the audited financial statements and the notes included in our latest annual financial statements included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2010. The results of operations for the quarter or nine months ended December 31, 2010 are not necessarily indicative of the results that may be expected for the full fiscal year ending March 31, 2011.

NOTE 3. RECENT ACCOUNTING PRONOUNCEMENTS
We have adopted all recently issued accounting pronouncements. The adoption of the accounting pronouncements, including those not yet effective, is not anticipated to have a material effect on our financial position or results of operations.

NOTE 4. NET INCOME PER SHARE
Net income per basic share is computed based on the weighted-average number of common shares issued and outstanding during each period. Net income per diluted share amounts assume conversion, exercise or issuance of all potential common stock instruments (stock options and warrants). Stock options and warrants totaling 1,000 for the quarter and nine months ended December 31, 2010 and 5,000 for the quarter and nine months ended December 31, 2009 were not included in the computation of diluted earnings per share because the exercise prices of the options and warrants were greater than the market price of the common stock. The following table reflects the components of common shares outstanding:

	Quarter Ended Dec. 31
	2010	2009
Weighted average common shares outstanding – basic	4,743,643	4,700,583
Effect of dilutive securities:
Stock options	115,789	149,309
Warrants	7,185	6,056
Shares used in computing net income per share – diluted	4,866,617	4,855,948

	Nine Months Ended Dec. 31
	2010	2009
Weighted average common shares outstanding – basic	4,714,989	4,689,849
Effect of dilutive securities:
Stock options	115,789	149,245
Warrants	7,185	6,056
Shares used in computing net income per share – diluted	4,837,963	4,845,150

Table of Contents

NOTE 5. MARKETABLE SECURITIES
Marketable securities with remaining maturities less than one year are classified as short-term, and those with remaining maturities greater than one year are classified as long-term. The fair value of our marketable securities as of December 31, 2010 were as follows:

Total			<1 Year			1–3 Years			3–5 Years
$	57,132,411		$	4,455,249		$	30,449,543		$	22,227,619

As of December 31 and March 31, 2010, our marketable securities were as follows:

	As of December 31, 2010									As of March 31, 2010
	Adjusted Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Market Value		Adjusted Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Market Value
U.S. agency securities	$	90,002	$	1,527	$	-		$	91,529	$	702,992	$	19,240	$	-		$	722,232
Corporate bonds		33,624,646		1,271,950		(112,646	)		34,783,950		23,807,375		1,029,273		(23,601	)		24,813,047
Municipal bonds	21,653,378		608,723		(5,169		)	22,256,932		21,877,258		747,483		(5,542		)	22,619,199
Total	$	55,368,026	$	1,882,200	$	(117,815	)	$	57,132,411	$	46,387,625	$	1,795,996	$	(29,143	)	$	48,154,478

The following table shows the gross unrealized losses and fair value of our investments with unrealized losses, aggregated by investment category and length of time that individual securities had been in a continuous unrealized loss position as of December 31 and March 31, 2010:

		Less Than 12 Months							12 Months or Greater						Total
		Fair Market Value			Gross Unrealized Losses				Fair Market Value			Gross Unrealized Losses			Fair Market Value			Gross Unrealized Losses
As of December 31, 2010
	U.S. agency securities	$	-		$	-			$	-		$	-		$	-		$	-
	Corporate bonds	4,910,424		(112,646			)	-			-			4,910,424			(112,646			)
	Municipal bonds	946,449			(5,169		)		-			-			946,449			(5,169		)
	Total	$	5,856,873		$	(117,815	)		$	-		$	-		$	5,856,873		$	(117,815	)
As of March 31, 2010
	U.S. agency securities	$	-		$	-			$	-		$	-		$	-		$	-
	Corporate bonds	2,032,306		(23,601			)	-			-			2,032,306			(23,601			)
	Municipal bonds	1,564,416			(5,542		)		-			-			1,564,416			(5,542		)
	Total	$	3,596,722		$	(29,143	)		$	-		$	-		$	3,596,722		$	(29,143	)

Gross unrealized losses totaled $117,815 as of December 31, 2010, and were attributable to four corporate bonds and one municipal bond out of a portfolio of 55 bonds. The gross unrealized losses were due to market-price decreases after the bonds were purchased. All of the bonds with an unrealized loss were rated A1/A+ or better by Moody’s or Standard and Poor’s, none had been downgraded since they were purchased, and none had been in a continuous unrealized loss position for 12 months or more. For each bond with an unrealized loss, we expect to recover the entire cost basis of each security based on our consideration of factors including their credit ratings, the underlying ratings of insured bonds, and historical default rates for securities of comparable credit rating. Because we expect to recover the entire cost basis of the securities, and because we do not intend to sell the securities and it is not more likely than not that we will be required to sell the securities before recovery of the cost basis, which may be maturity, we did not consider any of our marketable securities to be other-than-temporarily impaired at December 31, 2010.

Table of Contents

NOTE 6. COMPREHENSIVE INCOME
The components of comprehensive income are as follows:

	Quarter Ended Dec. 31
	2010			2009
Net income	$	3,383,919		$	2,767,483
Unrealized (loss) gain from marketable securities, net of tax	(533,498		)		35,175
Comprehensive income	$	2,850,421		$	2,802,658

	Nine Months Ended Dec. 31
	2010			2009
Net income	$	9,691,026		$	8,400,598
Unrealized (loss) gain from marketable securities, net of tax	(16,399		)		1,284,997
Comprehensive income	$	9,674,627		$	9,685,595

NOTE 7. INVENTORIES
Inventories consisted of the following:

	Dec. 31 2010			March 31 2010
Raw materials	$	1,799,146		$	595,032
Work in process		1,089,106			794,091
Finished goods	575,906			617,304
		3,464,158			2,006,427
Less inventory reserve	(300,000		)	(300,000		)
Total inventories	$	3,164,158		$	1,706,427

NOTE 8. STOCK-BASED COMPENSATION
There was no stock-based compensation expense for the third quarters of fiscal 2011 or 2010. Stock-based compensation expense was $76,720 for the first nine months of fiscal 2011 compared to $100,842 for the first nine months of fiscal 2010. Stock-based compensation expenses for the nine months ended December 31, 2010 and 2009 were non-cash and primarily due to the issuance of automatic stock options to our non-employee directors on their reelection to our Board. The decrease in stock-based compensation for the nine months ended December 31, 2010 compared to the prior-year period was primarily due to a lower stock price at the date of grant compared to the prior year. We calculate the share-based compensation expense on a straight-line basis over the vesting periods of the related share-based awards.

NOTE 9. INCOME TAXES
Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Tax provisions of $160,015 for the nine months ended December 31, 2010 and $280,448 for the nine months ended December 31, 2009 were credited to “Additional paid-in capital.”

We had no unrecognized tax benefits as of December 31, 2010, and we do not expect any significant unrecognized tax benefits within 12 months of the reporting date. We recognize interest and penalties related to income tax matters in income tax expense. As of December 31, 2010 we had no accrued interest related to uncertain tax positions. The tax years 1999 through 2009 remain open to examination by the major taxing jurisdictions to which we are subject.

NOTE 10. FAIR VALUE MEASUREMENTS
Generally accepted accounting principles establish a framework for measuring fair value, provide a definition of fair value and prescribe required disclosures about fair-value measurements. Generally accepted accounting principles define fair value as the price that would be received to sell an asset or paid to transfer a liability. Fair value is a market-based measurement that should be determined using assumptions that market participants would use in pricing an asset or liability. Generally accepted accounting principles utilize a valuation hierarchy for disclosure of fair value measurements. The categorization within the valuation hierarchy is based on the lowest level of input that is significant to the fair value measurement. The categories within the valuation hierarchy are described as follows:

Table of Contents

Level 1 – Financial instruments with quoted prices in active markets for identical assets or liabilities. Our Level 1 financial instruments consist of publicly-traded marketable debt securities that are classified as available-for-sale. On the balance sheets, available-for-sale securities are classified as “Marketable securities, short term” and “Marketable securities, long term.” The fair value of our available-for-sale securities was $57,132,411 at December 31, 2010 and $48,154,478 at March 31, 2010.

Level 2 – Financial instruments with quoted prices in active markets for similar assets or liabilities. Level 2 fair value measurements are determined using either prices for similar instruments or inputs that are either directly or indirectly observable, such as interest rates. We do not have any financial assets or liabilities being measured at fair value that are classified as Level 2 financial instruments.

Level 3 – Inputs to the fair value measurement are unobservable inputs or valuation techniques. We do not have any financial assets or liabilities being measured at fair value that are classified as Level 3 financial instruments.

NOTE 11. STOCK REPURCHASE PLAN
On January 21, 2009 we announced that our Board of Directors authorized the repurchase of up to $2,500,000 of our Common Stock. The repurchase program may be modified or discontinued at any time without notice. We did not repurchase any of our Common Stock during the quarter ended December 31, 2010.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Forward-looking statements
Some of the statements made in this Report or in the documents incorporated by reference in this Report and in other materials filed or to be filed by us with the Securities and Exchange Commission (“SEC”) as well as information included in verbal or written statements made by us constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are subject to the safe harbor provisions of the reform act. Forward-looking statements may be identified by the use of the terminology such as may, will, expect, anticipate, intend, believe, estimate, should, or continue, or the negatives of these terms or other variations on these words or comparable terminology. To the extent that this Report contains forward-looking statements regarding the financial condition, operating results, business prospects or any other aspect of NVE, you should be aware that our actual financial condition, operating results and business performance may differ materially from that projected or estimated by us in the forward-looking statements. We have attempted to identify, in context, some of the factors that we currently believe may cause actual future experience and results to differ from their current expectations. These differences may be caused by a variety of factors, including but not limited to risks associated with competition, progress in research and development activities by us and others, decreased sales, failure of suppliers to meet our requirements, inability to meet customer technical requirements, inability to consummate license agreements, ineligibility for SBIR awards, inability to renew agreements with large customers, risks of losses on our marketable securities, and other specific risks that may be alluded to in this Report or in the documents incorporated by reference in this Report.

Further information regarding our risks and uncertainties are contained in Part I, Item 1A “Risk Factors” of our Annual Report on Form 10-K for the year ended March 31, 2010, as updated in Part II, Item 1A of our Quarterly Report on Form 10-Q for the quarter ended June 30, 2010, Part II, Item 1A of our Quarterly Report on Form 10-Q for the quarter ended September 30, 2010, and Part II, Item 1A of this Quarterly Report on Form 10-Q .

General
NVE Corporation, referred to as NVE, we, us, or our, develops and sells devices that use spintronics, a nanotechnology that relies on electron spin rather than electron charge to acquire, store and transmit information. We manufacture high-performance spintronic products including sensors and couplers that are used to acquire and transmit data. We have also licensed our spintronic magnetoresistive random access memory technology, commonly known as MRAM.

Critical accounting policies
A description of our critical accounting policies is provided in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended March 31, 2010. At December 31, 2010 our critical accounting policies and estimates continued to include research and development contract percentage of completion estimation, inventory valuation, allowance for doubtful accounts estimation, and deferred tax assets estimation.

Table of Contents

Quarter ended December 31, 2010 compared to quarter ended December 31, 2009
The table shown below summarizes the percentage of revenue and quarter-to-quarter changes for various items:

	Percentage of Revenue Quarter Ended Dec. 31				Quarter- to-Quarter Change
	2010		2009		Quarter- to-Quarter Change
Revenue
Product sales	84.0	%	79.9	%	26.3	%
Contract research and development	16.0	%	20.1	%	(4.2	)%
Total revenue	100.0	%	100.0	%	20.2	%
Cost of sales	30.9	%	31.7	%	17.1	%
Gross profit	69.1	%	68.3	%	21.7	%
Expenses
Selling, general, and administrative	8.0	%	8.3	%	16.3	%
Research and development	4.2	%	3.8	%	31.4	%
Total expenses	12.2	%	12.1	%	21.0	%
Income from operations	56.9	%	56.2	%	21.8	%
Interest and other income	6.5	%	6.2	%	23.5	%
Income before taxes	63.4	%	62.4	%	22.0	%
Provision for income taxes	20.9	%	20.6	%	21.4	%
Net income	42.5	%	41.8	%	22.3	%

Total revenue for the quarter ended ended December 31, 2010 (the third quarter of fiscal 2011) increased 20% to $7,963,508 compared to $6,624,857 for the quarter ended ended December 31, 2009 (the third quarter of fiscal 2010). The increase was due to a 26% increase in product sales, partially offset by a 4% decrease in contract research and development revenue.

The increase in product sales from the prior-year quarter was due to the addition of new customers and increased purchase volume by existing customers. Until last fiscal year, our product sales had been less in quarters ended December 31 than the immediately preceding quarters in every year since fiscal 2007. This seasonality may have been due in part to distributor ordering patterns or customer vacations and shutdowns late in calendar years. This sequential decrease did not occur in fiscal 2010 or 2011, possibly due to the addition of new customers, increased purchase volume by existing customers, or improved economic environments. We cannot predict whether seasonal weakness in quarters ending December 31 will return in future fiscal years, and we cannot predict the possible impact of economic conditions on future results of operations. Furthermore, in every year since fiscal 2007 our product sales have increased in quarters ended March 31 from the quarters ended December 31, but we cannot predict whether this pattern will continue this fiscal year.

The decrease in research and development revenue was due to the completion of certain contracts and contract activities. Contract research and development activities can fluctuate for a number of reasons, some of which are beyond our control, and there can be no assurance of additional or follow-on contracts for expired or completed contracts.

Gross profit margin increased to 69% of revenue for the third quarter of fiscal 2011 compared to 68% for the third quarter of fiscal 2010, due to a more favorable revenue mix.

Total expenses increased 21% for the third quarter of fiscal 2011 compared to the third quarter of fiscal 2010 due to a 16% increase in selling, general, and administrative expense and a 31% increase in research and development expense. The increase in selling, general, and administrative expense was due to an increase in performance-based compensation and commissions, and the timing of professional services. The increase in research and development expense was due to increased product development activities. Research and development expense can fluctuate significantly depending on staffing, project requirements, and contract research and development activities.

Interest income increased 24% to $512,203 for the third quarter of fiscal 2011 compared to $414,669 for the third quarter of fiscal 2010. The increase was due to an increase in interest-bearing marketable securities.

The provision for income taxes was $1,661,090 for the third quarter of fiscal 2011 compared to $1,368,590 for the third quarter of fiscal 2010. The effective tax rate was 33% of income before taxes for the third quarter of fiscal 2011, which was approximately the same rate as the prior-year quarter. Our effective tax rate can fluctuate, however, due to a number of factors, some of which are outside our control.

The 22% increase in net income in the second quarter of fiscal 2011 compared to the prior-year quarter was primarily due to increased product sales.

Table of Contents

Nine months ended December 31, 2010 compared to nine months December 31, 2009
The table shown below summarizes the percentage of revenue and period-to-period changes for various items:

	Percentage of Revenue Nine Months Ended Dec. 31				Period- to-Period Change
	2010		2009		Period- to-Period Change
Revenue
Product sales	83.8	%	80.1	%	20.5	%
Contract research and development	16.2	%	19.9	%	(6.1	)%
Total revenue	100.0	%	100.0	%	15.3	%
Cost of sales	31.0	%	29.9	%	19.5	%
Gross profit	69.0	%	70.1	%	13.5	%
Expenses
Selling, general, and administrative	8.3	%	9.0	%	5.2	%
Research and development	4.3	%	4.1	%	21.2	%
Total expenses	12.6	%	13.1	%	10.2	%
Income from operations	56.4	%	57.0	%	14.2	%
Interest and other income	6.5	%	5.9	%	26.1	%
Income before taxes	62.9	%	62.9	%	15.3	%
Provision for income taxes	20.8	%	20.8	%	15.3	%
Net income	42.1	%	42.1	%	15.4	%

Total revenue for the nine months ended December 31, 2010 increased 15% to $23,013,962 compared to $19,967,890 for the nine months ended December 31, 2009. The increase was due to a 21% increase in product sales, partially offset by a 6% decrease in contract research and development revenue.

The increase in product sales from the prior-year period was due to the addition of new customers and increased purchase volume by existing customers.

The decrease in research and development revenue was due to the completion of certain contracts and contract activities. Contract research and development activities can fluctuate for a number of reasons, some of which are beyond our control, and there can be no assurance of additional or follow-on contracts for expired or completed contracts.

Gross profit margin decreased to 69% of revenue for the first nine months of fiscal 2011 compared to 70% for the first nine months of fiscal 2010, due to a less favorable product sales mix.

Total expenses increased 10% for the first nine months of fiscal 2011 compared to the first nine months of fiscal 2010 due primarily to a 21% increase in research and development expense. The increase in research and development expense was due to increased product development activities, and a decrease in contract research and development activities, which caused resources to be reallocated to expensed research and development activities. Research and development expense can fluctuate significantly depending on staffing, project requirements, and contract research and development activities.

Interest income increased 26% to $1,485,664 for the first nine months of fiscal 2011 compared to $1,177,892 for the first nine months of fiscal 2010. The increase was due to an increase in interest-bearing marketable securities.

The provision for income taxes was $4,782,699 for the first nine months of fiscal 2011 compared to $4,148,270 for the first nine months of fiscal 2010. The effective tax rate was 33% of income before taxes for the first nine months of fiscal 2011, which was approximately the same rate as the prior-year period. Our effective tax rate can fluctuate, however, due to a number of factors, some of which are outside our control.

The 15% increase in net income in the first nine months of fiscal 2011 compared to the prior-year period was primarily due to increased product sales and increased interest income.

Table of Contents

Liquidity and capital resources
At December 31, 2010 we had $58,310,820 in cash plus short-term and long-term marketable securities compared to $49,543,766 at March 31, 2010. Our entire portfolio of short-term and long-term marketable securities is classified as available for sale. The increase in cash plus marketable securities in the first nine months of fiscal 2011 was primarily due to $8,952,319 in net cash provided by operating activities.

The $2,888,583 increase in short-term marketable securities in the first nine months of fiscal 2011 was due to marketable securities previously classified as long-term approaching maturity. We expect short-term marketable securities to increase in the remaining quarter of the fiscal year as more of our securities approach maturity.

Accounts receivable decreased $750,129 dollars due to the timing of payments by our customers.

Inventories increased by $1,457,731 due to raw material purchase timing and to support an increased rate of product sales.

We had no deferred revenue as of December 31, 2010 compared to $20,833 at March 31, 2010. Deferred revenue at March 31, 2010 was due to a nonrefundable payment of $250,000 by Avago to us under the terms of Amendment No. 2 to an agreement between us and Agilent. We recognized revenue from the payment over the term of Amendment No. 2, which was effective as of June 27, 2007 and ended June 27, 2010.

Purchases of fixed assets were $501,957 during the nine months ended December 31, 2010, primarily for production equipment.

Proceeds from maturities and sales of marketable securities were $1,573,370 for the nine months ended December 31, 2010 compared to $175,256 for the nine months ended December 31, 2009. The increase was due to the maturation of marketable securities.

We currently believe our working capital is adequate for our needs at least for the next 12 months.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.
The primary objective of our investment activities is to preserve principal while at the same time maximizing after-tax yields without significantly increasing risk. To achieve this objective, we maintain our portfolio of cash equivalents and marketable securities in a variety of securities including government agency obligations, municipal obligations, corporate obligations, and money market funds. Short-term and long-term marketable securities are generally classified as available-for-sale and consequently are recorded on the balance sheet at fair value with unrealized gains or losses reported as a separate component of accumulated other comprehensive income, net of estimated tax. Marketable securities as of December 31, 2010 had remaining maturities between five and 58 months. Our short-term and long-term marketable securities had a fair market value of $57,132,411 at December 31, 2010, representing approximately 85% of our total assets. We have not used derivative financial instruments in our investment portfolio.

Item 4. Controls and Procedures.
Management, with the participation of the Chief Executive Officer and Chief Financial Officer, has performed an evaluation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (Exchange Act)) as of the end of the period covered by this report. This evaluation included consideration of the controls, processes and procedures that are designed to ensure that information required to be disclosed by us in the reports we file under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Based on such evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were effective.

During the quarter ended December 31, 2010, there was no change in our internal control over financial reporting that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

PART II–OTHER INFORMATION

Item 1A. Risk Factors.
There have been no material changes from the risk factors disclosed in our Annual Report on Form 10-K for the fiscal year ended March 31, 2010 as updated in our Quarterly Reports on Form 10-Q for the quarters ended June 30, 2010 and September 30, 2010, except the risk factors titled “We may lose revenue if we are unable to renew agreements with large customers” and “We could incur losses on our marketable securities” are replaced in their entirety by the following:

We may lose revenue if we are unable to renew agreements with large customers.
Our Supplier Partnering Agreement with St. Jude Medical, as amended, expires December 31, 2011; our agreement with Avago Technologies, Inc., as amended, expires June 27, 2013; and our Phonak AG Supply Agreement, as amended, expires March 31, 2015. We cannot predict if any of these agreements will be renewed, or if renewed, under what terms. Although it is possible we could continue to sell products to these customers without formal agreements, an inability to agree on mutually acceptable terms or the loss of any of these large customers could have a significant adverse impact on our revenue and our profitability.

This risk factor is being updated because we executed an amendment that extended the term of our Phonak AG Supply Agreement.

We could incur losses on our marketable securities.
At December 31, 2010, we held $57,132,411 in short-term and long-term marketable securities, representing approximately 85% of our total assets. For the first nine months of the fiscal year ending March 31, 2011 we earned $1,485,664 in interest, virtually all of which was from those securities. During the past two fiscal years a number of the securities we hold were downgraded by Moody’s or Standard and Poor’s indicating a possible increase in default risk. The credit crisis may have caused or contributed to many of these downgrades. Conditions and circumstances beyond our control or ability to anticipate can cause downgrades and increases in default risk. For example, in fiscal 2011 guaranteed global notes issued by BP Capital Markets plc that we hold were downgraded due to the impact of BP’s Macondo subsea well oil spill on BP’s financial profile. Although we recovered an unrealized loss in BP securities, downgrades of any of our marketable securities are possible at any time for reasons beyond our control, which could cause us to incur losses on those securities. Additionally, the assignment of a high credit rating does not preclude the risk of default on any marketable security. Losses for any reason on our marketable securities could have a material adverse impact on our financial condition, income, or cash flows.

The value of our marketable securities, the portion of our total assets in marketable securities, and interest earned are being updated in this risk factor.

Item 6. Exhibits.

Exhibit #	Description

10.1+	Amendment to Supply Agreement by and between NVE Corporation and Phonak AG (incorporated by reference to our Current Report on Form 8-K/A filed January 12, 2011).
31.1	Certification by Daniel A. Baker pursuant to Rule 13a-14(a)/15d-14(a).
31.2	Certification by Curt A. Reynders pursuant to Rule 13a-14(a)/15d-14(a).
32	Certification by Daniel A. Baker and Curt A. Reynders pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

+Confidential portions of this exhibit were deleted and filed separately with the SEC under a request for confidential treatment pursuant to Rule 24b-2 or Rule 406.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	NVE CORPORATION
	(Registrant)

January 19, 2011	/s/ DANIEL A. BAKER
Date	Daniel A. Baker
	President and Chief Executive Officer

January 19, 2011	/s/ CURT A. REYNDERS
Date	Curt A. Reynders
	Chief Financial Officer

TABLE OF CONTENTS

Part I Financial Information Note 2. Interim Financial Information Note 3. Recent Accounting Pronouncements Note 4. Net Income Per Share Note 6. Comprehensive Income Note 7. Inventories Inventories Consisted Of The Following:Note 7. Inventories Note 8. Stock-based Compensation Note 9. Income Taxes Note 10. Fair Value Measurements Note 11. Stock Repurchase Plan Item 2. Management S Discussion and Analysis Of Financial Condition and Results Of Operations. Forward-looking Statements Item 3. Quantitative and Qualitative Disclosures About Market Risk Item 4. Controls and Procedures Part II Other Information Item 1A. Risk Factors Item 6. Exhibits

NVEC 10-Q Quarter ended Dec. 31, 2010